199
Views
1
CrossRef citations to date
0
Altmetric
Research Paper

Is there any association of apolipoprotein E gene polymorphisms with metabolic syndrome in a young population of Croatian origin?

, , , , &
Pages 287-294 | Received 15 Apr 2015, Accepted 07 Jun 2016, Published online: 02 Sep 2016

References

  • Alberti K, Zimmet P, Shaw J. 2005. The metabolic syndrome – a new worldwide definition. Lancet 366:1059–1062.
  • Alvim RO, Freitas SRS, Ferreira NE, Santos PCJL, Cunha RS, Mill JG, et al. 2010. APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Lipids Health Dis 9:128.
  • Andreassi MG. 2009. Metabolic syndrome, diabetes and atherosclerosis: Influence of gene-environment interaction. Mutat Res-Fund Mol M 667:35–43.
  • Babio N, Bullo M, Basora J, Martinez-Gonzalez MA, Fernandez-Ballart J, Marquez-Sandoval F, et al. 2009. Adherence to the Mediterranean diet and risk of metabolic syndrome and its components. Nutr Metab Cardiovas 19:563–570.
  • Balwierz A, Polus A, Razny U, Wator L, Dyduch G, Tomaszewska R, et al. 2009. Angiogenesis in the New Zealand obese mouse model fed with high fat diet. Lipids Health Dis 8:13.
  • Boer JM, Ehnholm C, Menzel HJ, Havekes LM, Rosseneu M, O'Reilly DS, Tiret L. 1997. Interactions between lifestyle-related factors and the ApoE polymorphism on plasma lipids and apolipoproteins. The EARS Study. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 17:1675–1681.
  • Bu GJ. 2009. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10:333–344.
  • Camargo A, Meneses ME, Perez-Martinez P, Delgado-Lista J, Rangel-Zuniga OA, Marin C, et al. 2014. Dietary fat modifies lipid metabolism in the adipose tissue of metabolic syndrome patients. Genes Nutr 9:409. doi:10.1007/s12263-014-0409-3.
  • Carmel JF, Tarnus E, Cohn JS, Bourdon E, Davignon J, Bernier L. 2009. High expression of Apolipoprotein E impairs lipid storage and promotes cell proliferation in human adipocytes. J Cell Biochem 106:608–617.
  • Chiba T, Nakazawa T, Yui K, Kaneko E, Shimokado K. 2003. VLDL induces adipocyte differentiation in ApoE-dependent manner. Arterioscl Throm Vas 23:1423–1429.
  • Cho S-W, Kang J-Y, Park Y-K, Paek Y-M, Choi T-I. 2009. A 12-week worksite health promotion program reduces cardiovascular risk factors in male workers with the apolipoprotein E2 and apolipoprotein E3 genotypes, but not in apolipoprotein E4 genotype. Nutr Res 29:542–550.
  • Dallongeville J, Lussiercacan S, Davignon J. 1992. Modulation of plasma triglyceride levels by apoe phenotype – a metaanalysis. J Lipid Res 33:447–454.
  • Das UN, Puskas LG. 2009. Transgenic fat-1 mouse as a model to study the pathophysiology of cardiovascular, neurological and psychiatric disorders. Lipids Health Dis 8:61.
  • De Luis DA, Castrillon JLP, Duenas A. 2009. Leptin and obesity. Minerva Med 100:229–236.
  • Deka R, Durakovic Z, Niu W, Zhang G, Karns R, Smolej-Narancic N, et al. 2012. Prevalence of metabolic syndrome and related metabolic traits in an island population of the Adriatic. Ann Hum Biol 39:46–53.
  • DePaoli AM. 2014. Leptin in common obesity and associated disorders of metabolism. J Endocrinol 223:T71–T81.
  • Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115–121.
  • Eckel RH, Alberti KGMM, Grundy SM, Zimmet PZ. 2010. The metabolic syndrome. Lancet 375:181–183.
  • Eisenberg DTA, Kuzawa CW, Hayes MG. 2010. Worldwide Allele Frequencies of the Human Apolipoprotein E Gene: climate, local adaptations, and evolutionary history. Am J Phys Anthropol 143:100–111.
  • Excoffier L, Laval G, Schneider S. 2005. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evolut Bioinformat Online 1:47–50.
  • Ferreira DC, Costa TF, Aguiar SLF, Marques ARS, Ramos SA, Gomes KB, Alvarez-Leite JI. 2011. Association of Apoliprotein E polymorphisms and metabolic syndrome in subjects with extreme obesity. Clin Chim Acta 412:1559–1562.
  • Gao JH, Katagiri H, Ishigaki Y, Yamada T, Ogihara T, Imai J, et al. 2007. Involvement of apolipoprotein E in excess fat accumulation and insulin resistance. Diabetes 56:24–33.
  • Gotsis E, Anagnostis P, Mariolis A, Vlachou A, Katsiki N, Karagiannis A. 2015. Health benefits of the mediterranean diet: an update of research over the last 5 years. Angiology 66:304–318.
  • Grundy SM. 2006. Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 5:294–309.
  • Grundy SM, Neeland IJ, Turer AT, Vega GL. 2014. Ethnic and gender susceptibility to metabolic risk. Metab Syndr Relat D 12:110–116.
  • Guo SW, Thompson EA. 1992. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48:361–372.
  • Huang ZH, Espiritu DJ, Uy A, Holterman AX, Vitello J, Mazzone T. 2011. Adipose tissue depot-specific differences in adipocyte apolipoprotein E expression. Metabolism 60:1692–1701.
  • Huang ZH, Gu D, Mazzone T. 2009. Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo. Am J Physiol Endocrinol Metab 296:E1110–1119.
  • Huang ZH, Luque RM, Kineman RD, Mazzone T. 2007. Nutritional regulation of adipose tissue apolipoprotein E expression. Am J Physiol Endocrinol Metab 293:E203–209.
  • Huang ZH, Reardon CA, Mazzone T. 2006. Endogenous ApoE expression modulates adipocyte triglyceride content and turnover. Diabetes 55:3394–3402.
  • Hwang YC, Hayashi T, Fujimoto WY, Kahn SE, Leonetti DL, McNeely MJ, Boyko EJ. 2015. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obesity 39:1365–1370.
  • Karmelic I, Lovric J, Bozina T, Ljubic H, Vogrinc Z, Bozina N, Sertic J. 2012. Adiponectin level and gene variability are obesity and metabolic syndrome markers in a young population. Arch Med Res 43:145–153.
  • Kaur J. 2014. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:943162.
  • Khunti K, Davies M. 2005. Metabolic syndrome - Independently raises cardiovascular risk and should be picked up in primary care. BMJ 331:1153–1154.
  • Koch W, Hoppmann P, Schomig A, Kastrati A. 2008. Apolipoprotein E gene epsilon 2/epsilon 3/epsilon 4 polymorphism and myocardial infarction: case-control study in a large population sample. Int J Cardiol 125:116–117.
  • Kolcic I, Polasek O,Vuletic S. 2010. Scale and dynamics of overweight and obesity epidemic in croatia. Obesity facts. 3: 333.
  • Kypreos KE. 2009. Mechanisms of obesity and related pathologies. Febs J 276:5719–5719.
  • Kypreos KE, Karagiannides I, Fotiadou EH, Karavia EA, Brinkmeier MS, Giakoumi SM, Tsompanidi EM. 2009. Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity. Febs J 276:5720–5728.
  • Lai LYH, Petrone AB, Pankow JS, Arnett DK, North KE, Ellison RC, et al. 2015. Lack of association of apolipoprotein E (Apo E) polymorphism with the prevalence of metabolic syndrome: the National Heart, Lung and Blood Institute Family Heart Study. Diabetes-Metab Res 31:582–587.
  • Lasrich D, Bartelt A, Grewal T, Heeren J. 2015. Apolipoprotein E promotes lipid accumulation and differentiation in human adipocytes. Exp Cell Res 337:94–102.
  • Li XT, Du YM, Du YF, Huang XH. 2003. Association of apolipoprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2:175–179.
  • Loos RJF. 2012. Genetic determinants of common obesity and their value in prediction. Best Pract Res Cl En 26:211–226.
  • Luptakova L, Sivakova D, Cvicelova M, Wsolova L, Dankova Z, Michnova A, Blazicek P. 2013. Power of biomarkers and their relative contributions to metabolic syndrome in Slovak adult women. Ann Hum Biol 40:132–138.
  • Ma SJ, Xu SZ. 2015. Semiparametric nonlinear regression for detecting gene and environment interactions. J Stat Plan Infer 156:31–47.
  • Matsuzawa Y. 2006. The metabolic syndrome and adipocytokines. Febs Lett 580:2917–2921.
  • Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215–1215.
  • Moreno JA, Perez-Jimenez F, Marin C, Gomez P, Perez-Martinez P, Moreno R, et al. 2004. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects. J Nutr 134:2517–2522.
  • Murdoch SJ, Boright AP, Paterson AD, Zinman B, Steffes M, Cleary P, et al. 2007. LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes. Atherosclerosis 192:138–147.
  • Nauck M, Hoffmann MM, Wieland H, Marz W. 2000. Evaluation of the apo E genotyping kit on the Light-Cycler. Clin Chem 46:722–724.
  • Nevajda B, Havelka-Mestrovic A, Bilic M, Nevajda AP, Romic D, Vuletic V, et al. 2013. Prevalence of the metabolic syndrome in the old institutionalized people in Zagreb, Croatia. Collegium Antropol 37:203–206.
  • Phillips CM. 2013. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients 5:32–57.
  • Povel CM, Boer JMA, Reiling E, Feskens EJM. 2011. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 12:952–967.
  • Sertic J, Juricic L, Ljubic H, Bozina T, Lovric J, Markeljevic J, et al. 2009. Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity. BMC Res Notes 2:203.
  • Sima A, Lordan A, Stancu C. 2007. Apolipoprotein E polymorphism - a risk factor for metabolic syndrome. Clin Chem Lab Med 45:1149–1153.
  • Stojanovic S, Ilic MD, Ilic S, Petrovic D, Djukic S. 2015. The significance of adiponectin as a biomarker in metabolic syndrome and/or coronary artery disease. Vojnosanit Pregl 72:779–784.
  • Talmud PJ. 2007. Gene-environment interaction and its impact on coronary heart disease risk. Nutr Metab Cardiovas 17:148–152.
  • Thaman RaAG. 2013. Metabolic Syndrome: definition and pathophysiology - the discussion goes on! J Physiol Pharmacol Adv 3:48–56.
  • Tortosa A, Bes-Rastrollo M, Sanchez-Villegas A, Basterra-Gortari FJ, Nunez-Cordoba JM, Martinez-Gonzalez MA. 2007. Mediterranean diet inversely associated with the incidence of metabolic syndrome: The SUN prospective cohort. Diabetes Care 30:2957–2959.
  • Vucinic N, Djan I, Stokic E, Bozin B, Obreht D, Stankov K, Djan M. 2014. Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia). Mol Biol Rep 41:5221–5227.
  • Wei LK, Menon S, Griffiths LR, Gan SH. 2015. Signaling pathway genes for blood pressure, folate and cholesterol levels among hypertensives: an epistasis analysis. J Hum Hypertens 29:99–104.
  • Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ. 1997. The LightCycler(TM) a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22:176–181.
  • Yang WJ, Kelly T, He J. 2007. Genetic epidemiology of obesity. Epidemiol Rev 29:49–61.
  • Zarkesh M, Daneshpour MS, Faam B, Hedayati M, Azizi F. 2012. Is there any association of apolipoprotein E gene polymorphism with obesity status and lipid profiles? Tehran Lipid and Glucose Study (TLGS). Gene 509:282–285.
  • Zeljko HM, Skaric-Juric T, Narancic NS, Tomas Z, Baresic A, Salihovic MP, et al. 2011. E2 allele of the apolipoprotein E gene polymorphism is predictive for obesity status in Roma minority population of Croatia. Lipids Health Dis 10: 9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.